George Sellers
Stock Analyst at Stephens & Co.
(0.82)
# 2,886
Out of 4,435 analysts
49
Total ratings
25%
Success rate
-19.39%
Average return
Main Sectors:
11 Stocks
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
FNA Paragon 28 | Reiterates: Overweight | $18 | $7.69 | +134.07% | 3 | Apr 5, 2024 | |
CUTR Cutera | Reiterates: Overweight | $10 | $2.15 | +365.12% | 9 | Mar 22, 2024 | |
ANIK Anika Therapeutics | Reiterates: Equal-Weight | $22 | $25.65 | -14.23% | 5 | Mar 14, 2024 | |
ENOV Enovis | Initiates: Overweight | $72 | $50.27 | +43.23% | 1 | Feb 13, 2024 | |
ESTA Establishment Labs Holdings | Reiterates: Overweight | $47 | $52.23 | -10.01% | 6 | Jan 11, 2024 | |
APYX Apyx Medical | Maintains: Overweight | $8 → $5 | $1.65 | +203.03% | 2 | Nov 10, 2023 | |
TFX Teleflex | Reiterates: Overweight | $275 | $209.07 | +31.53% | 8 | Nov 3, 2023 | |
VCEL Vericel | Reiterates: Overweight | $44 | $47.70 | -7.76% | 1 | Sep 21, 2023 | |
TMCI Treace Medical Concepts | Reiterates: Equal-Weight | $25 | $5.88 | +325.17% | 4 | Sep 12, 2023 | |
STAA STAAR Surgical Company | Reiterates: Overweight | $57 | $41.53 | +37.25% | 6 | Aug 14, 2023 | |
GKOS Glaukos | Reiterates: Overweight | $71 | $112.72 | -37.01% | 4 | May 8, 2023 |
Paragon 28
Apr 5, 2024
Reiterates: Overweight
Price Target: $18
Current: $7.69
Upside: +134.07%
Cutera
Mar 22, 2024
Reiterates: Overweight
Price Target: $10
Current: $2.15
Upside: +365.12%
Anika Therapeutics
Mar 14, 2024
Reiterates: Equal-Weight
Price Target: $22
Current: $25.65
Upside: -14.23%
Enovis
Feb 13, 2024
Initiates: Overweight
Price Target: $72
Current: $50.27
Upside: +43.23%
Establishment Labs Holdings
Jan 11, 2024
Reiterates: Overweight
Price Target: $47
Current: $52.23
Upside: -10.01%
Apyx Medical
Nov 10, 2023
Maintains: Overweight
Price Target: $8 → $5
Current: $1.65
Upside: +203.03%
Teleflex
Nov 3, 2023
Reiterates: Overweight
Price Target: $275
Current: $209.07
Upside: +31.53%
Vericel
Sep 21, 2023
Reiterates: Overweight
Price Target: $44
Current: $47.70
Upside: -7.76%
Treace Medical Concepts
Sep 12, 2023
Reiterates: Equal-Weight
Price Target: $25
Current: $5.88
Upside: +325.17%
STAAR Surgical Company
Aug 14, 2023
Reiterates: Overweight
Price Target: $57
Current: $41.53
Upside: +37.25%
Glaukos
May 8, 2023
Reiterates: Overweight
Price Target: $71
Current: $112.72
Upside: -37.01%